Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    POP6792
Show Display Options
Rank Status Study
1 Completed Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Condition: Neoplasm Malignant
Intervention: Drug: Cabazitaxel (XRP6258)

Indicates status has not been verified in more than two years